FDA’s Conditional Approval Plan Would Unleash Biotech Innovation forbes.com/sites/greglich… “We’re going to be rolling out a new pathway for drugs, which is a pathway based on a plausible mechanism,” This is exactly what $NWBO needs to make DCVax-L available for patients suffering